We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Anaphylaxis and Related Events Following COVID‐19 Vaccination: A Systematic Review.
- Authors
Paul, Pradipta; Janjua, Emmad; AlSubaie, Mai; Ramadorai, Vinutha; Mushannen, Beshr; Vattoth, Ahamed Lazim; Khan, Wafa; Bshesh, Khalifa; Nauman, Areej; Mohammed, Ibrahim; Bouhali, Imane; Khalid, Mohammed; Zakaria, Dalia
- Abstract
The coronavirus disease 2019 (COVID‐19), induced by the severe acute respiratory syndrome coronavirus 2, is responsible for a global pandemic following widespread transmission and death. Several vaccines have been developed to counter this public health crisis using both novel and conventional methods. Following approval based on promising efficacy and safety data, the AstraZeneca, Janssen, Moderna, Pfizer/BioNTech, and Sinovac vaccines have been administered globally among different populations with various reported side effects. Reports of life‐threatening anaphylaxis following administration were of particular concern for both health care providers and the public. A systematic literature search using PubMed, Embase, Scopus, Web of Science, Science Direct, MedRxiv, and Lens.org databases identified relevant studies reporting anaphylaxis following vaccine administration. This systematic review includes 41 studies reporting anaphylaxis. A total of 7942 cases, including 43 deaths, were reported across 14 countries. Most cases occurred following the administration of the first dose. Importantly, the benefits of vaccination outweigh the risks of anaphylaxis. Subsequently, as populations continue to get vaccinated, it is important for health care providers to be able to recognize individuals at risk of developing anaphylaxis. Furthermore, they must be familiar with both the clinical hallmarks and treatment of anaphylactic reactions to minimize long‐term sequalae and prevent death in vaccinated individuals.
- Subjects
ANAPHYLAXIS; ONLINE information services; MEDICAL information storage &; retrieval systems; COVID-19 vaccines; SYSTEMATIC reviews; VACCINE effectiveness; MEDLINE; DEATH; PATIENT safety; DISEASE risk factors
- Publication
Journal of Clinical Pharmacology, 2022, Vol 62, Issue 11, p1335
- ISSN
0091-2700
- Publication type
Article
- DOI
10.1002/jcph.2120